Phimosis: A rare complication of immunotherapy with durvalumab

A clinical overview of people living with HIV and genitourinary cancer care

PDCD1 Gene - GeneCards, PDCD1 Protein

Luis Guillermo LLORENTE PETERS, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Tlalpan, INNSZ, Immunology & Rheumatology

Enfortumab Vedotin Approved for Recurrent Bladder Cancer - NCI

Oncology – Uros Associats - Especialistas en Urología en Barcelona y Tarragona

Jorge Arturo Alatorre Alexander - INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS

50631 PDFs Review articles in VITILIGO

Exploring the role of natural bioactive molecules in genitourinary cancers: how far has research progressed?

Luis G. Vázquez-Lavista MD - México, Perfil profesional

Breakdown of phimosis referrals

Frontiers Liver injury during durvalumab-based immunotherapy is associated with poorer patient survival: A retrospective analysis

Luis G. Vázquez-Lavista MD - México, Perfil profesional

Phimosis: A rare complication of immunotherapy with durvalumab - ScienceDirect

Kim Discusses Data for Chemotherapy and Immunotherapy in Biliary Tract Cancers

Jorge ALATORRE ALEXANDER, Instituto Nacional de Enfermedades Respiratorias, Mexico City, INER, Lung Cáncer Clinic